Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic
Naveen Pemmaraju shared a post on X:
“Superb clinic and research teams working together in Team Pemm clinic.
Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, and Myeloproliferative Neoplasms this month!
From left to right: Naveen Pemmaraju, Michelle Golez, Terri Saenz, Rhona Pinsoy, Dr. Mir Lim, Dr. Kekejian, Rodney Haltom.”
Source: Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023